Cor Vasa 2012, 54(7-8):e258-e260 | DOI: 10.1016/j.crvasa.2012.05.014

Pericardial effusion as a first sign of systemic scleroderma

Peter Kružliaka,b, Gabriela Kováčováb, Štefan Baloghb
a Ústav normalnej a patologickej fyziológie Slovenskej akadémie vied, Bratislava, Slovenská republika
b V. interná klinika, Univerzitná nemocnica Bratislava, Bratislava, Slovenská republika

Keywords: Dyspnoe; Echokardiografia; Perikardiálna efúzia; Systémová skleróza

Received: April 16, 2012; Accepted: May 29, 2012; Published: July 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kružliak P, Kováčová G, Balogh Š. Pericardial effusion as a first sign of systemic scleroderma. Cor Vasa. 2012;54(7-8):e258-260. doi: 10.1016/j.crvasa.2012.05.014.
Download citation

References

  1. R.W. Battle, M.A. Davitt, S.M. Cooper, et al., Prevalence of pulmonary hypertension in limited and diffuse scleroderma, Chest 110 (1996) 1515-1519. Go to original source... Go to PubMed...
  2. R. Salerni, G.P. Rodnan, D.F. Leon, J.A. Shaver, Pulmonary hypertension in the CREST syndrome variant of scleroderma, Annals of Internal Medicine 86 (1977) 394-399. Go to original source...
  3. R.G. Ungerer, D.P. Tashkin, D. Furst, et al., Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis, American Journal of Medicine 75 (1983) 65-74. Go to original source...
  4. I. Murata, H. Kihara, S. Shinohara, K. Ito, Echocardiographic evaluation of pulmonary arterial hypertension in patients with systemic and related syndromes, Japanese Circulation Journal 56 (1992) 983-991. Go to original source...
  5. A. Deswal, W.P. Follansbee, Cardiac involvement in scleroderma, Rheumatic Diseases Clinics of North America 22 (1996) 841-860. Go to original source... Go to PubMed...
  6. V. Steen, T.A. Medsger, Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement, Arthritis and Rheumatism 48 (2003) 516-522. Go to original source... Go to PubMed...
  7. S. Generini, G. Fiori, A. Moggi Piqnone, et al., Systemic sclerosis. A clinical overview, Advances in Experimental Medicine and Biology 455 (1999) 73-83. Go to original source... Go to PubMed...
  8. R. Gowda, I. Khan, T. Sacchi, et al., Scleroderma pericardial disease presented with a large pericardial effusion-a case report, Angiology 52 (2001) 59-62. Go to original source... Go to PubMed...
  9. B. Bulkley, R. Ridolfi, W. Salyer, et al., Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction, Circulation 53 (1976) 483-490. Go to original source...
  10. W. D'Angelo, J. Fries, A. Masi, et al., Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. American Journal of Medicine 46 (1969) 428-440. Go to original source... Go to PubMed...
  11. W. Follansbee, E. Curtiss, T.J. Medsger, et al., Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. The New England Journal of Medicine 310 (1984) 142-148. Go to original source... Go to PubMed...
  12. V. Steen, The heart in systemic sclerosis, Current Rheumatology Reports 6 (2004) 137-140. Go to original source...
  13. F. Gaffney, R. Anderson, J. Nixon, et al., Cardiovascular function in patients with progressive systemic sclerosis (scleroderma), Clinical Cardiology 5 (1982) 569-576. Go to original source...
  14. J. Gottdiener, H. Moutsopoulos, J. Decker, Echocardiographic identification of cardiac abnormality in scleroderma and related disorders, American Journal of Medicine 66 (1979) 391-398. Go to original source... Go to PubMed...
  15. R. Langley, E. Treadwell, Cardiac tamponade and pericardial disorders in connective tissue diseases: case report and literature review, Journal of National Medical Association 86 (1994) 149-153.




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.